Filtered By:
Condition: Atrial Fibrillation
Countries: China Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 389 results found since Jan 2013.
Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary
Biomed Environ Sci. 2023 Aug 20;36(8):669-701. doi: 10.3967/bes2023.106.ABSTRACTIn the past 30 years, the accessibility and quality index of medical care have made remarkable progress in China, ranking the first among middle-income countries. Many cardiovascular technologies are at or near the world's leading level, and significant progress has been achieved in China solving the problem of "treatment difficulty" of cardiovascular diseases (CVD). However, due to the prevalence of unhealthy lifestyles among Chinese residents, a huge population with CVD risk factors, accelerated population aging, and other reasons, the incide...
Source: Biomedical and Environmental Sciences : BES - September 15, 2023 Category: Biomedical Science Authors: Writing Committee Of The Report On Cardiovascular Health And Diseases In China The Source Type: research
Association between long-term exposure to PM < sub > 2.5 < /sub > constituents and electrocardiographic abnormality: A nationwide longitudinal study in China
CONCLUSION: Differential associations between various constituents of PM2.5 and ECG abnormalities were found. The unequal toxicities for different chemical constituents of ambient particles on cardiovascular electrophysiological endpoints should be taken into consideration when considering the biological pathways linking PM2.5 and cardiovascular conditions.PMID:37572496 | DOI:10.1016/j.envint.2023.108130
Source: Environment International - August 12, 2023 Category: Environmental Health Authors: Xueyan Han Man Cao Zhaoyang Pan Jian Guo Dengmin Huang Wei Sun Jiarun Mi Pengfei Li Yuanli Liu Tao Xue Tianjia Guan Source Type: research
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry
Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the an...
Source: Thrombosis Journal - August 1, 2023 Category: Hematology Authors: Xiaoxia Liu, Guoze Feng, Sabrina Vogel Marler, Menno V Huisman, Gregory Y. H. Lip and Changsheng Ma Tags: Research Source Type: research
Association between polymorphisms in Connexin40 Gene (Cx40) and risk of atrial fibrillation: a meta-analysis based on 3, 452 subjects
CONCLUSION: The Cx40 polymorphisms were positively associated with AF in both populations, especially on -44 polymorphism.PMID:37382580 | DOI:10.1080/1354750X.2023.2227361
Source: Biomarkers - June 29, 2023 Category: Research Authors: Zheng Lian Zheng Ma Zhi-Li Zhang Pei-Lin Liu Guo-Yong Zhang Cai-Xia Guo Source Type: research
